These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31582219)

  • 1. Differentiation-inducing factor-1 prevents hepatic stellate cell activation through inhibiting GSK3β inactivation.
    Furukawa S; Yamaguchi M; Ooka A; Kikuchi H; Ishikawa T; Saito SY
    Biochem Biophys Res Commun; 2019 Nov; 520(1):140-144. PubMed ID: 31582219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic and antihepatofibrotic effect of honokiol via activation of GSK3β and suppression of Wnt/β-catenin pathway in hepatic stellate cells.
    Lee IH; Im E; Lee HJ; Sim DY; Lee JH; Jung JH; Park JE; Shim BS; Kim SH
    Phytother Res; 2021 Jan; 35(1):452-462. PubMed ID: 32776713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo.
    Kubokura N; Takahashi-Yanaga F; Arioka M; Yoshihara T; Igawa K; Tomooka K; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Matsumoto T; Kitazono T; Sasaguri T
    J Pharmacol Sci; 2015 Apr; 127(4):446-55. PubMed ID: 25913757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation-inducing factor-1 suppresses the expression of c-Myc in the human cancer cell lines.
    Jingushi K; Nakamura T; Takahashi-Yanaga F; Matsuzaki E; Watanabe Y; Yoshihara T; Morimoto S; Sasaguri T
    J Pharmacol Sci; 2013; 121(2):103-9. PubMed ID: 23357875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Catenin pathway is required for TGF-β1 inhibition of PPARγ expression in cultured hepatic stellate cells.
    Qian J; Niu M; Zhai X; Zhou Q; Zhou Y
    Pharmacol Res; 2012 Sep; 66(3):219-25. PubMed ID: 22706027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrogenic actions of acetaldehyde are β-catenin dependent but Wingless independent: a critical role of nucleoredoxin and reactive oxygen species in human hepatic stellate cells.
    Arellanes-Robledo J; Reyes-Gordillo K; Shah R; Domínguez-Rosales JA; Hernández-Nazara ZH; Ramirez F; Rojkind M; Lakshman MR
    Free Radic Biol Med; 2013 Dec; 65():1487-1496. PubMed ID: 23880292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
    Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
    Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kubohara Y; Homma Y; Shibata H; Oshima Y; Kikuchi H
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs.
    Takahashi-Yanaga F; Sasaguri T
    J Pharmacol Sci; 2009 Feb; 109(2):179-83. PubMed ID: 19179804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion.
    Arioka M; Takahashi-Yanaga F; Kubo M; Igawa K; Tomooka K; Sasaguri T
    Biochem Pharmacol; 2017 Aug; 138():31-48. PubMed ID: 28501501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice.
    Takahashi-Yanaga F; Yoshihara T; Jingushi K; Igawa K; Tomooka K; Watanabe Y; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Sasaguri T
    Biochem Pharmacol; 2014 Jun; 89(3):340-8. PubMed ID: 24670930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice.
    Osawa Y; Oboki K; Imamura J; Kojika E; Hayashi Y; Hishima T; Saibara T; Shibasaki F; Kohara M; Kimura K
    EBioMedicine; 2015 Nov; 2(11):1751-8. PubMed ID: 26870800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putative morphogen, DIF-1, of Dictyostelium discoideum activates Akt/PKB in human leukemia K562 cells.
    Kubohara Y; Hosaka K
    Biochem Biophys Res Commun; 1999 Oct; 263(3):790-6. PubMed ID: 10512759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway.
    Yoshihara T; Takahashi-Yanaga F; Shiraishi F; Morimoto S; Watanabe Y; Hirata M; Hoka S; Sasaguri T
    Mol Cancer; 2010 Sep; 9():245. PubMed ID: 20843378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin affects β-catenin pathway in hepatic stellate cell in vitro and in vivo.
    Cui L; Jia X; Zhou Q; Zhai X; Zhou Y; Zhu H
    J Pharm Pharmacol; 2014 Nov; 66(11):1615-22. PubMed ID: 24945564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 knockdown attenuates the ameliorative effects of ligustrazine on hepatic fibrosis by targeting hepatic stellate cell transdifferentiation.
    Lu C; Xu W; Zhang F; Shao J; Zheng S
    Toxicology; 2016 Jul; 365():35-47. PubMed ID: 27477297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/β-catenin signaling.
    MadanKumar P; NaveenKumar P; Manikandan S; Devaraj H; NiranjaliDevaraj S
    Toxicol Appl Pharmacol; 2014 Jun; 277(2):210-20. PubMed ID: 24657339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.